Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review
Sign Up to like & getrecommendations! Published in 2017 at "AIDS Research and Treatment"
DOI: 10.1155/2017/2345617
Abstract: Background Darunavir is a second-generation protease-inhibitor used with ritonavir (DRV/r) and two nucleoside reverse-transcriptase inhibitors as an option in first-line antiretroviral treatment (ART). Methods We systematically reviewed randomized controlled trials (RCTs) of DRV/r versus other… read more here.
Keywords: transcriptase inhibitors; ritonavir boosted; nucleoside reverse; ritonavir ... See more keywords